DHR
NYSE · Life Sciences Tools & Services
Danaher Corp
$190.48
-2.30 (-1.19%)
Analyst Consensus
Strong Buy
30
Analysts
Very High
Coverage
Price Target
Analyst Price Target
-17.0% upside
Low Target
$107.89
Average Target
$158.11
High Target
$252.83
Current Price
$190.48
Current
$190.48
$190.48
Target
$158.11
$158.11
$107.89
$158.11 avg
$252.83
Scenario Analysis
Bear Case
$107.89
-43.4%
Low target
Base Case
$158.11
-17.0%
Avg target
Bull Case
$252.83
+32.7%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$242.80
-21.5% from high
52-Week Low
$160.93
+18.4% from low
50-Day SMA
$227.23
-16.2% vs SMA
200-Day SMA
$209.48
-9.1% vs SMA
RSI (14)
39.9
Neutral
Target vs 52W High
$158.11
-34.9% vs high
Next Earnings Report
Jul 21, 2026 · Before Market Open
20d
until earnings
EPS Est: $1.85
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 34 | 85% | $369.21 | -26.4% |
| DHR | Strong Buy | 30 | 90% | $158.11 | -17.0% |
| A | Strong Buy | 28 | 79% | $64.69 | -51.3% |
| WAT | Buy | 28 | 57% | $189.60 | -49.4% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -57.1% |
| ILMN | Buy | 28 | 61% | $169.36 | -3.7% |
| MTD | Hold | 20 | 50% | $170.43 | -86.7% |
| WST | Strong Buy | 22 | 82% | $136.24 | -62.1% |